Capillary blood analyser for point-of-care testing
Nova Biomedical recently announced CE-mark certification for Allegro, a capillary blood analyser for point-of-care testing in primary care settings. Allegro and its StatStrip A companion meter provide 14 clinically important tests to monitor glycemic control, assess cardiac risk with a full lipids panel, and assess kidney function. All results are ready during the patient visit, simplifying clinic workflow and producing cost savings for providers, while offering clinical benefits for patients. All Allegro tests use easy capillary fingerstick sampling and disposable test cartridges or strips. To monitor glycemic control, Allegro provides HbA1c, glucose, and estimated average glucose tests. To assess cardiac risk, Allegro provides total, HDL, non-HDL, and LDL cholesterol tests, cholesterol/HDL ratio, and triglycerides tests. To assess kidney function, Allegro provides urine creatinine, urine albumin, and urine a1bumin/creatinine ratio, and blood creatinine with eGFR tests. Allegro is the only analyser that can measure HbAlc, lipids, glucose, and creatinine from a capillary sample. Its innovative design comprises dual measurement bays, which offers the ability to measure two cartridges simultaneously, doubling throughput and improving efficiency. Allegro’s companion meter wirelessly transmits results to the analyser, where they combine with all cartridge test results for one patient report. All results can be transmitted to electronic medical records for providers to review with patients during the visit. Having immediate results during the patient visit reduces clinic follow-up calls, letters, and patient re-visits, and improves patient satisfaction, compliance with care plans, and outcomes. The analysers’ HbA1c accuracy is certified by the National Glycohemoglobin Standardization program (NGSP), and total cholesterol and HDL cholesterol are certified by the U.S. Centers for Disease Control Cholesterol Reference Method Laboratory Network.